L ( period length )
nine months ended
nine months ended
 
notes
september 30 2020
september 30 2019
 
cash flows from operating activities
 
-loss/profit before income tax
-11397
9 708
 
adjustments to reconcile -loss/profit before income tax to cash flows
 
depreciation and amortisation
10526
9 505
 
impairment losses on financial assets at amortized cost
540
165
 
net loss/-gain on venture capital investments
96
-394
 
net -gain/loss on financial assets and liabilities at fair value through profit or loss
-3621
560
 
goodwill impairment
6430
–
 
gain on remeasurement of previously held interest in equity accounted associate
-46
-324
 
finance expenses
1868
864
 
share of loss of equity accounted associates and joint ventures
10327
580
 
net foreign exchange -gain/loss
-425
1 148
 
сash settled and equity settled share based payments
1380
1 177
 
other non-cash items
29
-14
 
net loss/-gain on disposal of intangible assets
11
-400
 
dividend revenue from venture capital investments
–
-8
 
impairment/-reversal of impairment of equity accounted associates
260
-60
 
impairment of intangible assets
56
630
 
change in operating assets and liabilities
 
decrease/-increase in accounts receivable
556
-1 402
 
decrease/-increase in prepaid expenses and advances to suppliers
37
-333
 
decrease in inventories and other assets
384
164
 
increase in accounts payable and accrued expenses
102
1 731
 
-increase/decrease in other non-current assets
-103
67
 
increase/-decrease in deferred revenue and customer advances
4213
-8 872
 
increase in financial assets at fair value through profit or loss
-375
-2 906
 
operating cash flows before interest income taxes and contingent consideration settlement
20568
11 120
 
dividends received from venture capital investments
–
7
 
settlement of contingent consideration of business combinations
–
-688
 
interest received
355
415
 
income tax paid
-2535
-2 972
 
net cash provided by operating activities
16520
7 018
 
cash flows from investing activities
 
cash paid for property and equipment
-4432
-3 360
 
cash paid for intangible assets
-2399
-2 181
 
dividends received from equity accounted associates
29
71
 
cash paid for acquisitions of subsidiaries net of cash acquired
-19
-7 900
 
settlement of initial fair value of the contingent consideration at acquisition date
-1132
 
cash paid for investments in equity accounted associates and joint ventures
-6577
-1 242
 
net cash used in investing activities
-13299
-15 508
 
cash flows from financing activities
 
payment of lease liabilities
-2956
-2 657
 
loans received net of bank commission
8474
 
proceeds from issuance of gdrs net of transaction costs paid
6
15 209
 
dividends paid by subsidiaries to non-controlling shareholders
-235
–
 
cash paid for treasury shares
–
-896
 
net cash provided by financing activities
10049
4 921
 
net increase/-decrease in cash and cash equivalents
13270
-3 569
 
effect of exchange differences on cash balances
1578
-328
 
cash and cash equivalents at the beginning of the period
9782
11 723
 
change in cash related to asset held for sale
-130
-1 006
 
cash and cash equivalents at the end of the period
24500
6 820